Google Changes EU Spam Policy Amid Antitrust Scrutiny 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Toyota Global Sales Fall as China Demand Slumps 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Add as a preferred source on Google
WALTHAM, Mass., April 11, 2018 -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2018 first quarter financial results before the opening of the market on Thursday, April 19, 2018. The Company will host a conference call at 8:00 a.m., Eastern Time on April 19, 2018 to discuss its financial results as well as business developments affecting the Company.
The conference call may be accessed in the United States by dialing 844-787-0799 and using the confirmation code 6096899. Internationally, the conference call may be accessed by dialing 661-378-9630 and using the same confirmation code. The earnings press release and accompanying condensed financial statements will be accessible from the Company's website at www.NeuroMetrix.com under the "Investor Relations" tab.
A replay of the conference call will be available starting two hours after the call by dialing 855-859-2056, domestically and 800-585-8367, internationally. The confirmation code to access the replay is 6096899. The replay will be available for one week after the conference call.
About NeuroMetrix
NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell®, an over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more information, please visit NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
[email protected]
Source: NeuroMetrix, Inc.
